Browse by Medical Category
Accepting New Patients
Chin Hur, MD is an Associate Professor of Medicine at Harvard Medical School and a nationally recognized expert in Barrett's Esophagus management.
Go To Programs
Go To Programs
Digestive Healthcare Center
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Chin Hur, MD is an Associate Professor of Medicine at Harvard Medical School, and Director of GI Health Outcomes Research at the Massachusetts General Hospital Gastrointestinal Unit.
Dr. Hur received his M.D. and M.P.H. degrees from Johns Hopkins University and completed his Internal Medicine residency at the Johns Hopkins Hospital. He subsequently completed his fellowship in Gastroenterology at the Beth Israel Deaconess Medical Center and then joined the faculty of the MGH Gastrointestinal Unit in 2002.
Dr. Hur's areas of clinical areas of interests include: gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal adenocarcinoma as well as gastrointestinal cancer screening. He is also interested in benign esophageal conditions such as eosinophilic esophagitis.
His research interest lies in outcomes research, with a focus on decision analysis and simulation disease modeling, and the application of these methodologies to the management of cancers and pre-malignant states (e.g. dysplasia) in the gastrointestinal tract. This management includes the identification of clinical predictors, diagnostic algorithms, and the optimization of treatment. As an acknowledged investigator in health outcomes research, he has been the recipient of numerous awards from the National Institutes of Health as well other research foundations.
Some of the specific projects that he has been involved with include a simulation disease model of Barrett's Esophagus and Esophageal Cancer, an analysis of the impact of the implementation of Virtual Colonoscopies for colorectal cancer (CRC) screening and the possible role for chemoprevention in cancer care.
View my most recent publications at PubMed
Aspirin use appears to reduce the risk of Barrett's esophagus, the largest known risk factor for esophageal cancer.
Back to Top